Abstract HSP90 (heat shock protein 90) is an ATP-dependent molecular chaperone involved
in a proper folding and maturation of hundreds of proteins. HSP90 is abundantly expressed …

Outcomes of melanoma patient treatment remain unsatisfactory despite accessibility of
oncoprotein-targeting drugs and immunotherapy. Here, we reported that 17 …

Aims: Molecular heterogeneity of breast cancer results in variation in morphology, metastatic
potential and response to therapy. We previously showed that breast cancer cell line sub …

Melanoma is a highly aggressive cancer with poor prognosis. Although more than 80% of
melanomas harbor an activating mutation in genes within the MAPK pathway, which are …

Chemotherapy resistance remains one of the major challenges in cancer treatment. Most of
the studies on drug resistance have focused on genetic evolution of cancer cells; however …

Breast cancer (BC) is responsible for the highest mortality and morbidity out of all the
cancers in women which is primarily due to both inter and intra-tumoral molecular …

Abstract HSP90 (heat shock protein 90) is an ATP-dependent molecular chaperone involved
in a proper folding and maturation of hundreds of proteins. HSP90 is abundantly expressed …

Hepatocellular carcinoma (HCC) is a lethal disease with a poor prognosis. It is the sixth most
common cancer in the world with high mortality; it is the third leading cause of death of all …